Comments
On account of growth in international business, Torrent Pharmaceuticals Ltd’s net profit grew by 38% and revenues by 20% in the first quarter of 2011-12, ended June 30, compared with the corresponding quarter last fiscal, the company said here.
While the revenues stood at Rs. 647 crore (Rs 541 crore), net profit was Rs 103 crore (Rs 74 crore).
On Monday, TPL’s share price at the BSE closed 1.52% down at Rs 644.70.
During Q1, domestic formulation business grew10% due to lower sales growth in acute therapies. International revenues grew by 19%. The Brazil business posted a growth of 21%. Operations in Germany-based Heumann witnessed a revenue growth of 20%, while the US operations posted a revenue growth of 56%. In Europe (other than Heumann), Russia & CIS and rest of the world, operations grew by 2%, and contract manufacturing business recorded a growth of 74%.
The total revenue expenditure on R&D was 5.1% of consolidated net sales and operating income.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.